- Adenovirus-Mediated Toxic Gene Therapy Using Cytosine Deaminase and Osteocalcin Promoter for the Treatment of Prostate Cancer
-
Park HS, Bae JH, Moon DG, Cho HY, Kao C, Gardner TA, Cheon J
- KMID: 1583951
- Korean J Urol.
- 2000 Dec;41(12):1437-1444.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Enhancement of Bystander Prostate Cancer Cell Killing by the Utilization of Bone Marrow Stromal Cells Genetically Engineered to Express Cytosine Deaminase
-
Kim SJ, Gardner TA, Ko SC, Kao C, Chung LW
- KMID: 1583473
- Korean J Urol.
- 2000 Aug;41(8):933-939.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Suicide Gene Therapy for Bladder Cancer Using a Recombinant Adenovirus Expressing Escherichia Coli Cytosine Deaminase
-
Ahn M, Lim HY, Kao C, Gardner TA, Ko SC, Kim SJ
- KMID: 1990951
- Korean J Urol.
- 2003 Mar;44(3):244-249.
PURPOSE: The poor prognosis of advanced bladder cancer requires the investigation of novel treatment modalities. In this study, we investigated the suicide gene therapy for bladder cancer, using the adenovirus-mediated... -
- CITED
-
- Close
- SHARE
-
- Close
- Tumor-specific Gene Therapy for Renal Cell Carcinoma Using MN/CA9-directed Replication-competent Adenovirus
-
Kim SJ, Ahn M, Lim HY, Chung CH, Gardner TA, Kao C, Lee SJ, Choi MK, Kim YS
- KMID: 2293490
- Korean J Urol.
- 2004 May;45(5):456-462.
PURPOSE: A new therapeutic approach is needed in patients with metastatic renal cell carcinoma (RCC) because of a dismal prognosis. MN/CA9 is a transmembrane glycoprotein that was first identified in... -
- CITED
-
- Close
- SHARE
-
- Close
